Carbon dioxide microbubbles-enhanced sonographically guided radiofrequency ablation: Treatment of patients with local progression of hepatocellular carcinoma

Radiation Medicine - Medical Imaging and Radiation Oncology

Volumn 26, Issue 2, 2008, Pages 92-97

  Miyamoto, Noriyuki ^a   Hiramatsu, Kazuhide ^a   Tsuchiya, Kazuhiko ^a   Sato, Yukihiko ^a  

^a Obihiro Kosei Hospital   (Japan)

Author keywords

Carbon dioxide gas; Hepatocellular carcinoma; Local tumor progression; Radiofrequency ablation

Indexed keywords

CARBON DIOXIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; FEMALE; HUMAN; LIVER CELL CARCINOMA; MALE; MICROBUBBLE; RADIOFREQUENCY ABLATION;

AGED; AGED, 80 AND OVER; CARBON DIOXIDE; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; CONTRAST MEDIA; DISEASE PROGRESSION; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMAGE ENHANCEMENT; LIVER; LIVER NEOPLASMS; MALE; MICROBUBBLES; MIDDLE AGED; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 46449117946     PISSN: 02882043     EISSN: 18625274     Source Type: Journal    
DOI: 10.1007/s11604-007-0198-3     Document Type: Article

References (34)

1. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003;362:1907-1917.
2. Makuuchi M, Kosuge T, Takayama T, Yamazaki S, Kakazu T, Miyagawa S, et al. Surgery for small liver cancers. Semin Surg Oncol 1993;9:298-304.
3. Shiratori Y, Shiina S, Imamura M, Kato N, Kanai F, Okudaira T, et al. Characteristic difference of hepatocellular carcinoma between hepatitis B-and C-viral infection in Japan. Hepatology 1995;22:1027-1033.
4. Jansen MC, van Hillegersberg R, Chamuleau RA, van Delden OM, Gouma DJ, van Gulik TM. Outcome of regional and local ablative therapies for hepatocellular carcinoma: a collective review. Eur J Surg Oncol 2005;31:331-347.
5. Chen RC, Liao LY, Wang CS, Chen WT, Wang CK, Li YH, et al. Carbon dioxide-enhanced sonographically guided percutaneous ethanol injection: treatment of patients with viable and recurrent hepatocellular carcinoma. AJR Am J Roentgenol 2003;181:1647-1652.
6. Numata K, Tanaka K, Kiba T, Matsumoto S, Iwase S, Hara K, et al. Nonresectable hepatocellular carcinoma: improved percutaneous ethanol injection therapy guided by CO(2)-enhanced sonography. AJR Am J Roentgenol 2001;177:789-798.
7. Sato M, Watanabe Y, Tokui K, Kawachi K, Sugata S, Ikezoe J. CT-guided treatment of ultrasonically invisible hepatocellular carcinoma. Am J Gastroenterol 2000;95:2102-2106.
8. Takeshima K, Kumada T, Kimura T, Nakano S. The usefulness of percutaneous ethanol injection therapy under guidance with carbon dioxide contrast enhanced ultrasound sonography. Nippon Rinsho 1998;56:1001-1006 (in Japanese).
9. Imari Y, Sakamoto S, Shiomichi S, Isobe H, Ikeda M, Satoh M, et al. Hepatocellular carcinoma not detected with plain US: treatment with percutaneous ethanol injection under guidance with enhanced US. Radiology 1992;185:497-500.
10. 2-enhanced sonographically guided radiofrequency ablation and transcatheter arterial chemoembolization for small hepatocellular carcinoma poorly defined on conventional sonography. J Clin Ultrasound 2007;35:78-81.
11. Ohmoto K, Yoshioka N, Tomiyama Y, Shibata N, Kawase T, Yoshida K, et al. Carbon dioxide-enhanced sonographically guided radiofrequency ablation plus transcatheter arterial chemoembolization for hepatocellular carcinoma. J Vasc Interv Radiol 2006;17:723-736.
12. Catalano O, Lobianco R, Esposito M, Siani A. Hepatocellular carcinoma recurrence after percutaneous ablation therapy: helical CT patterns. Abdom Imaging 2001;26:375-383.
13. Watanabe R, Matsumura M, Chen CJ, Kaneda Y, Fujimaki M. Characterization of tumor imaging with microbubble-based ultrasound contrast agent, sonazoid, in rabbit liver. Biol Pharm Bull 2005;28:972-977.
14. Lencioni RA, Allgaier HP, Cioni D, Olschewski M, Deibert P, Crocetti L, et al. Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology 2003;228:235-240.
15. Acunas B, Rozanes I. Hepatocellular carcinoma: treatment with transcatheter arterial chemoembolization. Eur J Radiol 1999;32:86-89.
16. Livraghi T, Bolondi L, Lazzaroni S, Marin G, Morabito A, Rapaccini GL, et al. Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis: a study on 207 patients. Cancer 1992;69:925-929.
17. Nakazawa T, Kokubu S, Shibuya A, Ono K, Watanabe M, Hidaka H, et al. Radiofrequency ablation of hepatocellular carcinoma: correlation between local tumor progression after ablation and ablative margin. AJR Am J Roentgenol 2007;188:480-488.
18. Hori T, Nagata K, Hasuike S, Onaga M, Motoda M, Moriuchi A, et al. Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation. J Gastroenterol 2003;38:977-981.
19. Lee JK, Chung YH, Song BC, Shin JW, Choi WB, Yang SH, et al. Recurrences of hepatocellular carcinoma following initial remission by transcatheter arterial chemoembolization. J Gastroenterol Hepatol 2002;17:52-58.
20. Koda M, Murawaki Y, Mitsuda A, Ohyama K, Horie Y, Suou T, et al. Predictive factors for intrahepatic recurrence after percutaneous ethanol injection therapy for small hepatocellular carcinoma. Cancer 2000;88:529-537.
21. Koda M, Ueki M, Maeda Y, Mimura K, Okamoto K, Matsunaga Y, et al. Percutaneous sonographically guided radiofrequency ablation with artificial pleural effusion for hepatocellular carcinoma located under the diaphragm. AJR Am J Roentgenol 2004;183:583-588.
22. Ohmoto K, Mimura N, Iguchi Y, Mitsui Y, Shimabara M, Kuboki M, et al. CT-guided percutaneous ethanol injection therapy for ultrasonically invisible hepatocellular carcinoma. Hepatogastroenterology 2002;49:297-299.
23. Minami Y, Kudo M, Kawasaki T, Chung H, Ogawa C, Shiozaki H. Treatment of hepatocellular carcinoma with percutaneous radiofrequency ablation: usefulness of contrast harmonic sonography for lesions poorly defined with B-mode sonography. AJR Am J Roentgenol 2004;183:153-156.
24. Minami Y, Kudo M, Kawasaki T, Chung H, Ogawa C, Shiozaki H. Percutaneous radiofrequency ablation guided by contrast-enhanced harmonic sonography with artificial pleural effusion for hepatocellular carcinoma in the hepatic dome. AJR Am J Roentgenol 2004;182:1224-1226.
25. Cioni D, Lencioni R, Bartolozzi C. Therapeutic effect of transcatheter arterial chemoembolization on hepatocellular carcinoma: evaluation with contrast-enhanced harmonic power Doppler ultrasound. Eur Radiol 2000;10:1570-1575.
26. Kudo M, Tomita S, Tochio H, Kashida H, Hirasa M, Todo A. Hepatic focal nodular hyperplasia: specific findings at dynamic contrast-enhanced US with carbon dioxide microbubbles. Radiology 1991;179:377-382.
27. 2 microbubbles. Radiology 1992;182:155-160.
28. Kudo M, Tomita S, Tochio H, Mimura J, Okabe Y, Kashida H, et al. Sonography with intraarterial infusion of carbon dioxide microbubbles (sonographic angiography): value in differential diagnosis of hepatic tumors. AJR Am J Roentgenol 1992;158:65-74.
29. Chen RC, Chen WT, Liao LY, Cheng NY, Wang CK, Tu HY, et al. Intravenous contrast-enhanced Doppler sonography and intra-arterial carbon dioxide-enhanced sonography in the assessment of hepatocellular carcinoma vascularity before and after treatment. Acta Radiol 2002;43:411-414.
30. 2 microbubbles. Radiology 1986;161:701-705.
31. Koito K, Namieno T, Hirokawa N, Ichimura T, Nishida M, Yama N, et al. Enhanced sonography using carbon dioxide gas for small hepatocellular carcinoma: a comparison study between pure carbon dioxide gas and carbon dioxide microbubbles. Radiat Med 2005;23:104-110.
32. Numata K, Tanaka K, Kiba T, Matsumoto S, Iwase S, Hara K, et al. Nonresectable hepatocellular carcinoma: improved percutaneous ethanol injection therapy guided by CO(2)-enhanced sonography. AJR Am J Roentgenol 2001;177:789-798 (in Japanese).
33. Barr R. ATL/Phillips ultrasound: seeking consensus-contrast ultrasound in radiology. Eur J Radiol 2002;41:207-216.
34. Kudo M, Hatanaka K, Chung H, Minami Y, Maekawa K. Sonazoid-enhanced ultrasonography, defect re-perfusion imaging, defect re-injection test. Kanzo 2007;48:299-301.